X0508 4 2025-06-04 0001662774 Quince Therapeutics, Inc. QNCX 0001613842 Benatti Luca C/O QUINCE THERAPEUTICS, INC. 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 true false Director Stock Option (Right to Buy) 1.09 2025-06-04 4 A 0 27000 0 A 2035-06-04 Common Stock 27000 27000 D The shares subject to the option shall vest 100% on the one-year anniversary of the grant date. The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2025 provided for under the issuer's Outside Director Compensation Policy. /s/ Brendan Hannah as attorney-in-fact for Luca Benatti 2025-06-06